Table 5.

T‐TAS Parameters, PT‐INR, and APTT in Patients With and Without Periprocedural Bleeding Events

	Without Bleeding Events (n=107)		With Bleeding Events (n=21)
	Day of CA	3 Days After CA	Day of CA	3 Days After CA	At Event
AR10‐AUC30	1805 [1702–1861]	1616 [1455–1722]	1525 [1447–1713]a	1437 [1205–1540]a	1390 [1246–1504]
PL24‐AUC10	411 [383–441]	422 [384–440]	364 [333–432]b	367 [307–421]b	363 [261–404]
PT‐INR	1.05 [1.01–1.09]	1.15 [1.07–1.25]	1.07 [1.03–1.10]	1.19 [1.09–1.33]	1.13 [1.08–1.21]
APTT, s	31.7 [29.5–34.4]	36.9 [31.7–43.7]	32.5 [30.7–35.1]	37.3 [34.0–43.8]	37.3 [33.6–41.6]

Values are expressed as median [25–75%]. APTT indicates activated partial thromboplastin time; AR₁₀‐AUC₃₀, area under the curve for the first 30 minutes for the atheroma chip tested at flow rate of 10 μL/min; CA, catheter ablation; PL₂₄‐AUC₁₀, area under the curve for the first 10 minutes for the platelet chip tested at flow rate of 24 μL/min.

^a P<0.001, without bleeding events vs with bleeding events at the day of CA or 3 days after CA.

^b P<0.05, without bleeding events vs with bleeding events at the day of CA or 3 days after CA.